We demonstrate that the pattern of BORIS occupancy in cancer cells expressing this protein largely recapitulates its binding in germ cells, suggesting that the ability of a CTCF binding region to be occupied by BORIS in vivo is encoded in the DNA sequence and the site’s architecture. The gene discussed is CTCFL; the disease is cancer.